Stocks-EDIT-Editas Medicine Inc

EDIT Editas Medicine Inc

0 0 (0%)
Market ClosedDelayed Prices By NASDAQ, in USD
Trade
Trade

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2022: Editas Medicine Inc's revenues decreased by 22.83% and amounted to 19.71M. Net income decreased by 14.51% to -220.43M. Net assets decreased by NaN to N/A and EPS decreased from N/A to -3.21.
EDIT's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
74.91%
Net Profit Margin
-662.78%
Operating Margin
-847.88%
Return On Investment
-41.17%